LUCENTIS® Non-English

(ranibizumab)

  • Product: LUCENTIS® 0.23 mg/Vial Non-English
  • Manufacturer: Novartis
  • Active Substance(s): Ranibizumab
  • Strength: 2.3mg
  • Pack Size: 1-0.23ml vial
  • Accessories: Package insert
  • B - Brand Name
  • RX - Prescription
  • europe - Europe

Product Information

Order Lucentis Non-English from Ace Medical Wholesale. Using human antibody fragment, this injectable ophthalmology solution helps prevent blood and fluid leakage to treat retinal eye diseases including wet age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy with DME, and myopic choroidal neovascularization. Inject this solution as required, every few weeks to months, to reduce the symptoms of retinal eye disease.